GLP-1s can cut the risk of Alzheimer’s. What does that mean for No­vo Nordisk?

4 months ago
R&D

On­col­o­gy biotech Ar­riVent does an­oth­er Chi­na ADC deal, this time with Lepu Bio­phar­ma

4 months ago
Startups
Deals

US with­draw­al from WHO could jeop­ar­dize in­for­ma­tion shar­ing

4 months ago
Pharma

Re­newed mifepri­s­tone fight will be ear­ly test of Trump’s abor­tion stance in his sec­ond term

4 months ago
Pharma
Law

J&J's Spra­va­to wins ex­pand­ed la­bel for de­pres­sion as sin­gu­lar treat­ment

4 months ago
Pharma
FDA+

Sanofi says no sup­ply in­ter­rup­tions af­ter land­ing FDA warn­ing let­ter for US site

4 months ago
FDA+
Manufacturing

What to make of Unit­ed­Health Group’s re­bate move

4 months ago
Health Tech

Chi­na's biotech boom is threat­en­ing US drug­mak­er­s' dom­i­nance

4 months ago
R&D
China

FDA puts Atara’s INDs on hold af­ter re­jec­tion; As­cle­tis' safe­ty da­ta for obe­si­ty pill

4 months ago
News Briefing

As­cen­t­age es­ti­mates $133M in pro­ceeds as it plans Nas­daq dual list­ing

4 months ago
Financing
China

With sup­port from NFL own­er Jef­frey Lurie, Ice­landic biotech clos­es Se­ries A for oral Alzheimer's drug

4 months ago
R&D

Ex­it­ing Medicare di­rec­tor ex­pects cur­rent law to guide next price ne­go­ti­a­tions

4 months ago
People
Pharma

Sion­na and Odyssey end JPM week with IPO fil­ings

4 months ago
Financing
Startups

An­oth­er US biotech emerges with drug can­di­date from Chi­na-based Keymed

4 months ago
Startups
Deals

JP­M's M&A Mon­day fren­zy; Ozem­pic se­lect­ed for IRA ne­go­ti­a­tions; Pfiz­er says it's back on track; and more

4 months ago
Weekly

Sage sues Bio­gen days af­ter $469M buy­out of­fer

4 months ago
Pharma
Law

FDA ap­proves As­traZeneca and Dai­ichi Sankyo’s ADC for breast can­cer de­spite lack of sur­vival ben­e­fit

4 months ago
R&D
FDA+

What Trump's CMS can and can't change with the sec­ond round of drug price ne­go­ti­a­tions

4 months ago
Law

WuXi AppTec sells med­ical de­vice test­ing unit; Lay­offs at Notch Ther­a­peu­tics

4 months ago
News Briefing

No­vo claims high-dose Phase 3 We­govy win but sales im­pact might be mut­ed

4 months ago
R&D
Pharma

Ozem­pic makes list for next round of Medicare drug price ne­go­ti­a­tions

4 months ago
Pharma

As­traZeneca wins BTK race to mar­ket in first-line man­tle cell lym­phoma

4 months ago
R&D

Kathy High leads GV, ARCH-backed eye dis­ease biotech; Arv­inas com­mer­cial ex­ec steps down

4 months ago
Peer Review

Af­ter three-month de­lay, Am­gen’s Lumakras clinch­es FDA green light in col­orec­tal can­cer

4 months ago
Pharma
First page Previous page 52535455565758 Next page Last page
A service from the Financial Times